SCHEMBL4293145

SCHEMBL4293145

COc1ccc(Cc2c(C)cc(COC(C)=O)cc2O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
SAE1 Q9UBE0 1/20 0.43
UBA2 Q9UBT2 1/20 0.43
IGF1R P08069 1/20 0.43
ALOX15 P16050 1/20 0.43
SLC5A1 P13866 1/20 0.42
SLC5A2 P31639 1/20 0.42
CYP3A4 P08684 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4291094 0.87 CYP19A1 (0.45) NFKB1NFKB2RELASAE1UBA2
SCHEMBL4288355 0.87 THRA (0.42) THRATHRBCYP3A4ALDH1A1SMN1; SMN2
SCHEMBL4291912 0.86 NFKB1 (0.42) NFKB1NFKB2RELASAE1UBA2
SCHEMBL4286746 0.86 NPSR1 (0.42) NFKB1NFKB2RELASAE1UBA2
SCHEMBL4284453 0.84 THRA (0.39) THRATHRBCYP3A4ALDH1A1
SCHEMBL27746660 0.84 THRA (0.48) THRATHRBNFKB1NFKB2RELA
SCHEMBL4294453 0.83 NFKB1 (0.40) NFKB1NFKB2RELASAE1UBA2
SCHEMBL4289242 0.80 CYP3A4 (0.47) NFKB1NFKB2RELASAE1UBA2
SCHEMBL3998037 0.78 IDH1 (0.48) THRATHRBIGF1RALOX15ALDH1A1
SCHEMBL1871228 0.77 ALDH1A1 (0.62) ALDH1A1NPC1RAB9AATMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 THRA 3664/4885THRB 3295/4885NFKB1 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.